000 | 01300 a2200349 4500 | ||
---|---|---|---|
005 | 20250517221920.0 | ||
264 | 0 | _c20190326 | |
008 | 201903s 0 0 eng d | ||
022 | _a1179-1950 | ||
024 | 7 |
_a10.1007/s40265-018-0923-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMaasumi, Kasra | |
245 | 0 | 0 |
_aCGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine. _h[electronic resource] |
260 |
_bDrugs _cJun 2018 |
||
300 |
_a913-928 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xantagonists & inhibitors |
650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide Receptor Antagonists _xpharmacology |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
650 | 0 | 4 |
_aReceptors, Calcitonin Gene-Related Peptide _ximmunology |
650 | 0 | 4 | _aSignal Transduction |
700 | 1 | _aMichael, Rebecca L | |
700 | 1 | _aRapoport, Alan M | |
773 | 0 |
_tDrugs _gvol. 78 _gno. 9 _gp. 913-928 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40265-018-0923-5 _zAvailable from publisher's website |
999 |
_c28497660 _d28497660 |